Trade Summary

2 days ago, Michaelson Jennifer, serving as Chief Scientific Officer at Cullinan Therapeutics, Inc. (CGEM), sold 8,000 shares at $14.62 per share, for a total transaction value of $116,996.00. Following this transaction, Michaelson Jennifer now holds 166,844 shares of CGEM.

This sale represents a 5.00% decrease in Michaelson Jennifer's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, May 5, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 6, 2026, 1 day after the trade was made.

Cullinan Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.